Daily non-political popular news in brief.

Bypassing eggs, flu vaccine grown in insect cells shows promise

04-10-2007 · EurekAlert!

An experimental flu vaccine made in insect cells -- not in eggs, where flu vaccines currently available in the United States are grown -- is safe and as effective as conventional vaccines in protecting people against the flu. Removing eggs from the flu vaccine manufacturing process could allow a vaccine to be produced in large amounts much more quickly, a key advantage if a bird flu pandemic were to occur.

Keywords: bypassing, eggs, flu, vaccine, grown, insect, cells, shows, promise, egg, cell, show

« Previous | Next »

Similar news on "Bypassing eggs, flu vaccine grown in insect cells shows promise":

Experimental flu vaccine appears promising in early tests
04-10-2007 · EurekAlert!
An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.
Similar news · Read more »
U of MN adult stem cell research shows promise for transplant therapies
01-15-2007 · EurekAlert!
University of Minnesota stem cell researchers, together with collaborators at Stanford University, have successfully used adult stem cells to replace the immune system and bone marrow of mice, offering the promise of new therapies for people in the future.
Similar news · Read more »
Stem cells show promise for treating Huntington's disease
09-25-2007 · EurekAlert!
Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease -- a fatal disorder for which there is currently no cure or even a treatment to slow the disease. Scientists used gene therapy to guide the development of endogenous stem cells in the brains of mice affected by a form of Huntington’s, generating new medium spiny neurons -- the cell lost in Huntington's disease.
Similar news · Read more »
Adult pig stem cells show promise in repairing animals' heart attack damage
11-13-2006 · EurekAlert!
Johns Hopkins scientists have successfully grown large numbers of stem cells taken from adult pigs' healthy heart tissue and used the cells to repair some of the tissue damage done to those organs by lab-induced heart attacks. Pigs' hearts closely resemble those in humans, making them a useful model in such research.
Similar news · Read more »
Signal protein shows promise for blocking tumor promoters in skin cells
11-03-2006 · EurekAlert!
A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon and breast cancers.
Similar news · Read more »
Bug versus Bug: Insect virus makes a viable flu vaccine
04-14-2007 · Science News Online
A new influenza vaccine churned out by caterpillar cells infected with a genetically engineered virus effectively prevents the flu.
Similar news · Read more »
Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
Researchers at IRB Barcelona discover a new mechanism that regulates stem cell division
03-05-2007 · EurekAlert!
Stem cells have the extraordinary capacity to divide producing two very distinct cells: one retains stem cell identity and continues to undergo asymmetric division, while the other specializes for a specific function and shows limited capacity to divide. This strategy allows a single stem cell to generate great amounts of tissue during a lifetime. Researchers at IRB Barcelona, have discovered that one of the key factors in asymmetric stem cell division is the behavior of centrosome.
Similar news · Read more »
Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
04-15-2007 · EurekAlert!
Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent. Results of their study, being presented today at the American Association for Cancer Research annual meeting, show the by-product to be more effective than currently used therapies at killing multiple myeloma cells.
Similar news · Read more »
Columbia University Medical Center researchers show leaky muscle cells lead to fatigue
02-11-2008 · EurekAlert!
What do marathoners and heart failure patients have in common? More than you think according to new findings by physiologists at Columbia University Medical Center. The new study shows that the fatigue that marathoners and other extreme athletes feel at the end of a race is caused by a tiny leak inside their muscles that probably also saps the energy from patients with heart failure.
Similar news · Read more »